95 related articles for article (PubMed ID: 16740437)
1. HIV-related oral lesions, demographic factors, clinical staging and anti-retroviral use.
Ramírez-Amador V; Anaya-Saavedra G; Calva JJ; Clemades-Pérez-de-Corcho T; López-Martínez C; González-Ramírez I; Sierra-Madero J
Arch Med Res; 2006 Jul; 37(5):646-54. PubMed ID: 16740437
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of oral and perioral manifestations in HIV positive adults at Tikur Anbessa Teaching Hospital Addis Ababa, Ethiopia.
Guteta S; Feleke Y; Fekade D; Neway M; Diro E
Ethiop Med J; 2008 Oct; 46(4):349-57. PubMed ID: 19271399
[TBL] [Abstract][Full Text] [Related]
3. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
Ortega KL; Vale DA; Magalhães MH
J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
[TBL] [Abstract][Full Text] [Related]
4. Oral manifestations of HIV infection in adult patients from the province of Sancti Spiritus, Cuba.
Carpio E; López V; Fardales V; Benítez I
J Oral Pathol Med; 2009 Jan; 38(1):126-31. PubMed ID: 19192058
[TBL] [Abstract][Full Text] [Related]
5. HIV infection: oral lesions, CD4+ cell count and viral load in an Italian study population.
Margiotta V; Campisi G; Mancuso S; Accurso V; Abbadessa V
J Oral Pathol Med; 1999 Apr; 28(4):173-7. PubMed ID: 10235371
[TBL] [Abstract][Full Text] [Related]
6. Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patients.
Kerdpon D; Pongsiriwet S; Pangsomboon K; Iamaroon A; Kampoo K; Sretrirutchai S; Geater A; Robison V
Oral Dis; 2004 May; 10(3):138-44. PubMed ID: 15089922
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population.
Bravo IM; Correnti M; Escalona L; Perrone M; Brito A; Tovar V; Rivera H
Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E33-9. PubMed ID: 16388291
[TBL] [Abstract][Full Text] [Related]
8. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study.
Tappuni AR; Fleming GJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Dec; 92(6):623-8. PubMed ID: 11740479
[TBL] [Abstract][Full Text] [Related]
9. Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults.
Chattopadhyay A; Caplan DJ; Slade GD; Shugars DC; Tien HC; Patton LL
Community Dent Oral Epidemiol; 2005 Feb; 33(1):35-44. PubMed ID: 15642045
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for oral hairy leukoplakia in HIV-infected adults of Brazil.
Moura MD; Grossmann Sde M; Fonseca LM; Senna MI; Mesquita RA
J Oral Pathol Med; 2006 Jul; 35(6):321-6. PubMed ID: 16762011
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy.
Kroidl A; Schaeben A; Oette M; Wettstein M; Herfordt A; Häussinger D
Eur J Med Res; 2005 Oct; 10(10):448-53. PubMed ID: 16287607
[TBL] [Abstract][Full Text] [Related]
12. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study.
Nicolatou-Galitis O; Velegraki A; Paikos S; Economopoulou P; Stefaniotis T; Papanikolaou IS; Kordossis T
Oral Dis; 2004 May; 10(3):145-50. PubMed ID: 15089923
[TBL] [Abstract][Full Text] [Related]
13. Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil.
da Silva CA; Dourado I; Dahia SR; Harzheim E; Rutherford GW
J Public Health Dent; 2008; 68(3):178-81. PubMed ID: 18248345
[TBL] [Abstract][Full Text] [Related]
14. Incidence of oral candidiasis and oral hairy leukoplakia in HIV-infected adults in North Carolina.
Chattopadhyay A; Caplan DJ; Slade GD; Shugars DC; Tien HC; Patton LL
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jan; 99(1):39-47. PubMed ID: 15599347
[TBL] [Abstract][Full Text] [Related]
15. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
16. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
[TBL] [Abstract][Full Text] [Related]
17. Cost implications for the treatment of five oral lesions commonly found in HIV/AIDS.
Adedigba MA; Naidoo S; Ogunbodede EO
Odontostomatol Trop; 2009 Mar; 32(125):17-24. PubMed ID: 19711837
[TBL] [Abstract][Full Text] [Related]
18. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
[TBL] [Abstract][Full Text] [Related]
19. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
[TBL] [Abstract][Full Text] [Related]
20. Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients.
Miziara ID; Weber R
Oral Dis; 2006 Jul; 12(4):402-7. PubMed ID: 16792726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
